{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:38:27Z","timestamp":1789519107767,"version":"build-2803163510"},"reference-count":70,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5P01AI073693"],"award-info":[{"award-number":["5P01AI073693"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH1910759"],"award-info":[{"award-number":["W81XWH1910759"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["5R01AG061381"],"award-info":[{"award-number":["5R01AG061381"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FRN168906"],"award-info":[{"award-number":["FRN168906"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FRN166184"],"award-info":[{"award-number":["FRN166184"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["5P01AI102852"],"award-info":[{"award-number":["5P01AI102852"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019310","name":"Feinstein Institutes for Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019310","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019311","name":"Northwell Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019311","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Methods &amp; Clinical Development"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.omtm.2025.101563","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T23:36:00Z","timestamp":1755128160000},"page":"101563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["AAV-mediated peripheral scFv's administration to reduce cerebral tau in adult P301S transgenic mice: Mono-vs. combination therapy"],"prefix":"10.1016","volume":"33","author":[{"given":"Sebica","family":"Katel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Cicalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Vasciaveo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Vecchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Carrion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leann","family":"Mahadeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricio T.","family":"Huerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janvi D.","family":"Choksi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Aubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Marambaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Giliberto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"d\u2019Abramo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2025.101563_bib1","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature","volume":"71","author":"Nelson","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.omtm.2025.101563_bib2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.omtm.2025.101563_bib3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0197-4580(95)00021-6","article-title":"Staging of alzheimer\u2019s disease-related neurofibrillary changes","volume":"16","author":"Braak","year":"1995","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.omtm.2025.101563_bib4","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/S0197-4580(97)00062-6","article-title":"Diagnostic Criteria for Neuropathologic Assessment of Alzheimer\u2019s Disease","volume":"18","author":"Braak","year":"1997","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.omtm.2025.101563_bib5","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/archneur.61.3.378","article-title":"Neurofibrillary Tangles Mediate the Association of Amyloid Load With Clinical Alzheimer Disease and Level of Cognitive Function","volume":"61","author":"Bennett","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.omtm.2025.101563_bib6","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1002\/mds.20539","article-title":"Tau gene mutations and their effects","volume":"20","author":"Goedert","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.omtm.2025.101563_bib7","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0925-4439(00)00037-5","article-title":"Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer\u2019s disease","volume":"1502","author":"Goedert","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omtm.2025.101563_bib8","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/31508","article-title":"Association of missense and 5\u2032-splice-site mutations in tau with the inherited dementia FTDP-17","volume":"393","author":"Hutton","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2025.101563_bib9","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41582-023-00883-2","article-title":"Tau-targeting therapies for Alzheimer disease: current status and future directions","volume":"19","author":"Congdon","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.omtm.2025.101563_bib10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau-targeting therapies for Alzheimer disease","volume":"14","author":"Congdon","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.omtm.2025.101563_bib11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.semcdb.2021.12.002","article-title":"Targeting tau only extracellularly is likely to be less efficacious than targeting it both intra- and extracellularly","volume":"126","author":"Congdon","year":"2022","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.omtm.2025.101563_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag0481","article-title":"Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy","volume":"9","author":"DeVos","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2025.101563_bib13","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/s41591-023-02326-3","article-title":"Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer\u2019s disease: a phase 1b, randomized, placebo-controlled trial","volume":"29","author":"Mummery","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2025.101563_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in Early Alzheimer\u2019s Disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtm.2025.101563_bib15","doi-asserted-by":"crossref","first-page":"362","DOI":"10.14283\/jpad.2023.30","article-title":"Lecanemab: Appropriate Use Recommendations","volume":"10","author":"Cummings","year":"2023","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.omtm.2025.101563_bib16","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13195-023-01321-7","article-title":"The therapeutic landscape of tauopathies: challenges and prospects","volume":"15","author":"Cummings","year":"2023","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.omtm.2025.101563_bib17","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug Transport across the Blood\u2013Brain Barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.omtm.2025.101563_bib18","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jalz.2009.06.003","article-title":"Alzheimer\u2019s disease drug development and the problem of the blood-brain barrier","volume":"5","author":"Pardridge","year":"2009","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.omtm.2025.101563_bib19","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/s41591-021-01455-x","article-title":"Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial","volume":"27","author":"Dam","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2025.101563_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/bs.pmbts.2019.06.001","article-title":"Alzheimer\u2019s therapy development: A few points to consider","volume":"168","author":"Sigurdsson","year":"2019","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.omtm.2025.101563_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.103338","article-title":"A call for better understanding of target engagement in Tau antibody development","volume":"27","author":"Bespalov","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.omtm.2025.101563_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062402","article-title":"Tau Passive Immunotherapy in Mutant P301L Mice: Antibody Affinity versus Specificity","volume":"8","author":"d\u2019Abramo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2025.101563_bib23","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E","article-title":"Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau","volume":"48","author":"Jicha","year":"1997","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.omtm.2025.101563_bib24","doi-asserted-by":"crossref","first-page":"9115","DOI":"10.1523\/JNEUROSCI.2361-07.2007","article-title":"Immunotherapy Targeting Pathological Tau Conformers in a Tangle Mouse Model Reduces Brain Pathology with Associated Functional Improvements","volume":"27","author":"Asuni","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.omtm.2025.101563_bib25","doi-asserted-by":"crossref","first-page":"35452","DOI":"10.1074\/jbc.M113.491001","article-title":"Antibody Uptake into Neurons Occurs Primarily via Clathrin-dependent Fc\u03b3 Receptor Endocytosis and Is a Prerequisite for Acute Tau Protein Clearance","volume":"288","author":"Congdon","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omtm.2025.101563_bib26","doi-asserted-by":"crossref","first-page":"33081","DOI":"10.1074\/jbc.M113.494922","article-title":"Two Novel Tau Antibodies Targeting the 396\/404 Region Are Primarily Taken Up by Neurons and Reduce Tau Protein Pathology","volume":"288","author":"Gu","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omtm.2025.101563_bib27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13024-024-00730-y","article-title":"Single-domain antibody-based protein degrader for synucleinopathies","volume":"19","author":"Jiang","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.omtm.2025.101563_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2016.09.019","article-title":"Camelid single-domain antibodies: A versatile tool for in vivo imaging of extracellular and intracellular brain targets","volume":"243","author":"Li","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.omtm.2025.101563_bib29","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.2174\/1570159X21666230830142554","article-title":"Recombinant Antibody Fragments for Neurological Disorders: An Update","volume":"22","author":"Manoutcharian","year":"2024","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.omtm.2025.101563_bib30","doi-asserted-by":"crossref","first-page":"16835","DOI":"10.1523\/JNEUROSCI.2755-14.2014","article-title":"Antibody-Derived In Vivo Imaging of Tau Pathology","volume":"34","author":"Krishnaswamy","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.omtm.2025.101563_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf3775","article-title":"Single-domain antibody\u2013based noninvasive in vivo imaging of \u03b1-synuclein or tau pathology","volume":"9","author":"Jiang","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtm.2025.101563_bib32","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s40478-018-0585-2","article-title":"Anti-tau conformational scFv MC1 antibody efficiently reduces pathological tau species in adult JNPL3 mice","volume":"6","author":"Vitale","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.omtm.2025.101563_bib33","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s40478-020-01003-7","article-title":"Intramuscular injection of vectorized-scFvMC1 reduces pathological tau in two different tau transgenic models","volume":"8","author":"Vitale","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.omtm.2025.101563_bib34","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1084\/jem.2016212505192017c","article-title":"Correction: AAV-mediated expression of anti-tau scFvs decreases tau accumulation in a mouse model of tauopathy","volume":"214","author":"Ising","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.omtm.2025.101563_bib35","doi-asserted-by":"crossref","first-page":"12425","DOI":"10.1523\/JNEUROSCI.2016-16.2016","article-title":"Vectored Intracerebral Immunization with the Anti-Tau Monoclonal Antibody PHF1 Markedly Reduces Tau Pathology in Mutant Tau Transgenic Mice","volume":"36","author":"Liu","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.omtm.2025.101563_bib36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13024-019-0340-6","article-title":"Targeting tauopathy with engineered tau-degrading intrabodies","volume":"14","author":"Gallardo","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.omtm.2025.101563_bib37","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.ymthe.2022.01.009","article-title":"Inhibition of Tau seeding by targeting Tau nucleation core within neurons with a single domain antibody fragment","volume":"30","author":"Danis","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101563_bib38","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.ymthe.2020.10.007","article-title":"Anti-tau scFvs Targeted to the Cytoplasm or Secretory Pathway Variably Modify Pathology and Neurodegenerative Phenotypes","volume":"29","author":"Goodwin","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101563_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104770","article-title":"Neuronally expressed anti-tau scFv prevents tauopathy-induced phenotypes in Drosophila models","volume":"137","author":"Krishnaswamy","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.omtm.2025.101563_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.101158","article-title":"Anti-tau intrabodies: From anti-tau immunoglobulins to the development of functional scFv intrabodies","volume":"31","author":"Rodrigues Martins","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101563_bib41","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.molimm.2022.02.006","article-title":"An adeno-associated virus-mediated immunotherapy for Alzheimer\u2019s disease","volume":"144","author":"Zhang","year":"2022","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.omtm.2025.101563_bib42","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00401-018-1869-0","article-title":"Selective targeting of 3 repeat Tau with brain penetrating single chain antibodies for the treatment of neurodegenerative disorders","volume":"136","author":"Spencer","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.omtm.2025.101563_bib43","doi-asserted-by":"crossref","first-page":"34457","DOI":"10.1074\/jbc.M111.229633","article-title":"Passive Immunization with Anti-Tau Antibodies in Two Transgenic Models","volume":"286","author":"Chai","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omtm.2025.101563_bib44","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1471-4159.2011.07337.x","article-title":"Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain","volume":"118","author":"Boutajangout","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.omtm.2025.101563_bib45","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.neurobiolaging.2012.05.010","article-title":"Sensitive quantitative assays for tau and phospho-tau in transgenic mouse models","volume":"34","author":"Acker","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.omtm.2025.101563_bib46","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/s41583-023-00710-z","article-title":"Assessments of dentate gyrus function: discoveries and debates","volume":"24","author":"Borzello","year":"2023","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.omtm.2025.101563_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.609123","article-title":"Dentate Granule Cells Recruited in the Home Environment Display Distinctive Properties","volume":"14","author":"Pl\u00e9au","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.omtm.2025.101563_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2013.00202","article-title":"Dynamic NMDAR-mediated properties of place cells during the object place memory task","volume":"7","author":"Faust","year":"2013","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.omtm.2025.101563_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2019.00071","article-title":"18F-FDG-PET in Mouse Models of Alzheimer\u2019s Disease","volume":"6","author":"Bouter","year":"2019","journal-title":"Front. Med."},{"key":"10.1016\/j.omtm.2025.101563_bib50","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature17427","article-title":"Thalamic reticular impairment underlies attention deficit in Ptchd1Y\/\u2212 mice","volume":"532","author":"Wells","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2025.101563_bib51","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1016\/j.neuron.2024.04.013","article-title":"The thalamic reticular nucleus orchestrates social memory","volume":"112","author":"Wang","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.omtm.2025.101563_bib52","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.brs.2017.01.004","article-title":"The human globus pallidus internus is sensitive to rewards \u2013 Evidence from intracerebral recordings","volume":"10","author":"M\u00fcnte","year":"2017","journal-title":"Brain Stimul."},{"key":"10.1016\/j.omtm.2025.101563_bib53","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S2215-0366(15)00579-9","article-title":"Precision psychiatry: a neural circuit taxonomy for depression and anxiety","volume":"3","author":"Williams","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.omtm.2025.101563_bib54","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.neubiorev.2015.07.014","article-title":"Resting-state functional connectivity in major depressive disorder: A review","volume":"56","author":"Mulders","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.omtm.2025.101563_bib55","doi-asserted-by":"crossref","first-page":"12707","DOI":"10.1523\/JNEUROSCI.1100-16.2016","article-title":"Neural Correlates of Fear in the Periaqueductal Gray","volume":"36","author":"Watson","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.omtm.2025.101563_bib56","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13024-023-00601-y","article-title":"Common mouse models of tauopathy reflect early but not late human disease","volume":"18","author":"Wenger","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.omtm.2025.101563_bib57","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3390\/cells12050785","article-title":"Various AAV Serotypes and Their Applications in Gene Therapy: An Overview","volume":"12","author":"Issa","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.omtm.2025.101563_bib58","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ymthe.2017.10.017","article-title":"Mapping the Structural Determinants Required for AAVrh.10 Transport across the Blood-Brain Barrier","volume":"26","author":"Albright","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101563_bib59","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.biopsych.2010.04.027","article-title":"Amygdala Activity, Fear, and Anxiety: Modulation by Stress","volume":"67","author":"Ressler","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.omtm.2025.101563_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/v11100920","article-title":"Internal Ribosome Entry Site Dramatically Reduces Transgene Expression in Hematopoietic Cells in a Position-Dependent Manner","volume":"11","author":"Zheng","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.omtm.2025.101563_bib61","doi-asserted-by":"crossref","first-page":"6661","DOI":"10.1038\/s41598-018-25049-9","article-title":"Human rhinovirus internal ribosome entry site element enhances transgene expression in transfected CHO-S cells","volume":"8","author":"Chai","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2025.101563_bib62","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1046\/j.1471-4159.1997.69052087.x","article-title":"A Conformation- and Phosphorylation-Dependent Antibody Recognizing the Paired Helical Filaments of Alzheimer\u2019s Disease","volume":"69","author":"Jicha","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.omtm.2025.101563_bib63","doi-asserted-by":"crossref","first-page":"9340","DOI":"10.1523\/JNEUROSCI.22-21-09340.2002","article-title":"Abundant Tau Filaments and Nonapoptotic Neurodegeneration in Transgenic Mice Expressing Human P301S Tau Protein","volume":"22","author":"Allen","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.omtm.2025.101563_bib64","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3233\/JAD-2012-121354","article-title":"Methods for Measuring Tau Pathology in Transgenic Mouse Models","volume":"33","author":"Forest","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.omtm.2025.101563_bib65","article-title":"Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-& #946; and Tau Neuropathology","volume":"123","author":"Miedel","year":"2017","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.omtm.2025.101563_bib66","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13024-016-0082-7","article-title":"Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy","volume":"11","author":"Barini","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.omtm.2025.101563_bib67","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","article-title":"Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model","volume":"53","author":"Yoshiyama","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.omtm.2025.101563_bib68","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/78078","article-title":"Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein","volume":"25","author":"Lewis","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2025.101563_bib69","doi-asserted-by":"crossref","DOI":"10.1038\/srep24250","article-title":"CALHM1 deficiency impairs cerebral neuron activity and memory flexibility in mice","volume":"6","author":"Vingtdeux","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2025.101563_bib70","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.neuroscience.2005.07.014","article-title":"A three-dimensional digital atlas database of the adult C57BL\/6J mouse brain by magnetic resonance microscopy","volume":"135","author":"Ma","year":"2005","journal-title":"Neuroscience"}],"container-title":["Molecular Therapy Methods &amp; Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125001585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125001585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:55:30Z","timestamp":1778867730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050125001585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2329050125001585"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101563","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AAV-mediated peripheral scFv's administration to reduce cerebral tau in adult P301S transgenic mice: Mono-vs. combination therapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101563","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"101563"}}